AV-TEMECULA-CT
Manufacturer adverse-event records for AV-TEMECULA-CT come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2008–2019 · heavy-book · elevated Death-code · injury-heavy
Volume signature
AV-TEMECULA-CT sits in the heavy MAUDE book
AV-TEMECULA-CT accounts for 77,603 FDA MAUDE reports (#42 of 443, heavy-book tercile). Death-coded event_type share is 3.22% (elevated); Injury share 62.8% (injury-heavy).
What the volume reading shows for AV-TEMECULA-CT
The standout signal for AV-TEMECULA-CT is filing volume: 77,603 adverse-event reports in FDA MAUDE (#42 of 443, heavy-book). Death-coded event_type share sits at 3.22% (elevated).
As a heavy-book manufacturer, portfolio size and reporting obligations inflate absolute counts - pair AV-TEMECULA-CT with device-family pages before treating company totals as a safety verdict. Event_type Death and Injury are one code per report; Patient Outcomes below use a separate FDA population.
Reports span 20 device types, led in this extract by Injury at 48,755 (62.8% of event_type total). Peak single-year volume reaches 10,159 reports across 12 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.